Author

S. Fross

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

A. K. Martino· 1 shared B. Palakurthi· 1 shared E. Howe· 1 shared I. H. Guldner· 1 shared Q. Wang· 1 shared R. A. Neff· 1 shared S. M. Golomb· 1 shared S. Zhang· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. K. Martino

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Maximizing the Anti-tumor Potential of Immune Checkpoint Blockade through Modulation of Myeloid-specific CXCL16 and STAT1 Signaling

B. Palakurthi, I. H. Guldner, X. Liu, A. K. Martino, Q. Wang, S. Fross, R. A. Neff, S. M. Golomb, E. Howe, S. Zhang

This study shows that modulating STAT1 signaling in chemotherapy-primed breast cancer enhances anti-PD-1 immunotherapy efficacy by altering myeloid cell dynamics.

bioRxiv · Mar 28, 2022 · PreprintCancer Biology